- Telehealth Visits
- Insurance plan information
S. John Liu, MD, PhD
Radiation Oncology- Telehealth Visits
- Insurance plan information
S. John Liu, MD, PhD
Radiation Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. S. John Liu is a radiation oncologist who cares for patients with brain tumors. He is interested in developing ways to maximize the efficacy of radiation for brain tumor treatment while minimizing its side effects.
Liu's research centers on improving brain tumor diagnosis and care, with a particular focus on malignant gliomas. He leads a research group spanning many disciplines that uses genetic information and techniques to identify next-generation targets for medical and radiation treatment of brain tumors.
Liu earned his medical degree and a doctorate in biomedical sciences at UCSF. He also completed a residency in radiation oncology at UCSF.
Education & training
Residency
- Radiation Oncology, University of CA at San Francisco - Pathology GME
Internship
- Internal Medicine, Kaiser Foundation Hospital - San Francisco
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
Conditions
- Hyperthermia
- Eye Cancer
- Plantar-Fascial Fibromatosis
- Dupuytren Contracture
Treatments
- Radiation Treatment
- Total Body Irradiation
- 3D Conformal Radiation Therapy
- Volumetric Modulated Arc Therapy
- Stereotactic Cranial Radiation
- Stereotactic Spine Radiosurgery
- Intraoperative Radiation Therapy
- Intensity-Modulated Radiation Therapy
- Image-Guided Radiation Therapy
Clinical Trials query: q=health_gateway_id_ss%3A%28%223741%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223741%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.